Boothbay Fund Management, LLC Axsome Therapeutics, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $327,096 - $505,959	5,600 Added 17.89%	36,900 $2.65 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $6.49 Million - $8.34 Million	-111,200 Reduced 78.04%	31,300 $1.93 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $5.69 Million - $11.4 Million	142,500 New	142,500 $11 Million
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $308,708 - $663,850	-14,200 Reduced 23.28%	46,800 $1.79 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $1.21 Million - $4.16 Million	61,000 New	61,000 $2.01 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.